司太立制药  Starry Pharmaceutical  
司太立制药创建于1997年，2011年3月改制为股份有限公司，是一家从事研发、生产、销售为一体的医药高新技术企业。

公司主要产品有X-CT非离子型造影剂碘海醇、碘佛醇、碘帕醇、碘克沙醇、碘普罗胺、碘美普尔等系列原料药及中间体；核磁共振造影剂钆贝葡胺、钆喷酸葡胺、钆特酸葡胺等原料药及中间体；氟喹喏酮类左氧氟沙星和甲磺酸帕珠沙星等系列原料药。是国内规模最大、品种最全的非离子型碘造影剂产品生产企业。

公司生产、安全、环保设施齐备，职业卫生管理规范、制度齐全、管理扎实，组织体系、研发体系、生产体系、质量体系、EHS管理体系、注册体系、文化体系、销售体系完善，是浙江省100强最具活力的中型企业之一。

公司的创业目标是在X-CT非离子型造影剂诊断药物和氟喹诺酮类抗菌药物领域成为国内领军企业。司太立制药秉承“聚合生命能量，呵护人类健康”的发展理念，将与全球医药行业同仁一起为人类健康事业作出贡献。公司热忱欢迎新老客户光临指导，诚邀各界人士精诚合作、共创辉煌！ 

Established in 1997, and incorporated in 2011, Zhejiang Starry Pharmaceutical Co., Ltd, is a vertically integrated high-technology pharmaceutical manufacturer in China.

Starry Pharmaceutical is the leading API manufacuturer of X-CT non-ionic contrast medium, MRI contrast medium and Fluoroquinolones portfolio, including Iohexol, Ioversol, Iopamidol, Iodixanol, Iopromide, Iomeprol, Gadobenate Dimeglumine, Gadopentetate Dimeglumine, Gadoterate meglumine, Levofloxacin Hemihydrate, Pazufloxacin mesylate. Core product Iohexol has the COS certificate. We have the largest production scale and cover all major range of X-CT non-ionic contrast medium in China.

Starry has state-of-the-art manufacturing facilities conforming to the most stringent international GMP, our plant is, EDQM, JMDA(Japan), ISO14001 certified, and is preparing the inspection by US FDA. Perfect organziation, R&D, production, quality assurance, regulatory support, EHS, cultural, and sales mangaement system make Starry as one of most dynamic top 100 medium enterprises in Zhejiang Province.

Starry’s mission is to become the leading manufacturer in X-CT nonionic contrast medium diagnose drug and fluoroquinolone antibacterials field.

"Focusing on product quality,serving the customer"is our forever principle. We cooperate sincerely with the global pharmaceutical industry and work together in serving human health undertaking!